PC 3 cancer cell line, which lacked the necessary CEACAM6 sites, was not susceptible to CEACAM6 antibodies; the results echo this, revealing a minimal reduction in terms of cell viability (Supplementary Materials, Figure S3; [30]). Here, CEACAM6 is linked to cancer.